Upgrade to SI Premium - Free Trial

Nephron Assumes Elevance (ELV) at Hold

April 20, 2026 4:19 PM
Nephron analyst Eric Percher assumes coverage on Elevance (NYSE: ELV) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

New Coverage